Literature DB >> 16690974

Pulmonary vascular endothelial growth factor-C in development and lung injury in preterm infants.

Joakim Janér1, Patrik Lassus, Caj Haglund, Karri Paavonen, Kari Alitalo, Sture Andersson.   

Abstract

RATIONALE: In mice, vascular endothelial growth factor-C (VEGF-C) plays an important role in development of the lymphatic system and in pathogenesis of pulmonary inflammation. Its role in development of the lymphatic system in human lung and in lung injury in newborns remains unclear.
OBJECTIVES: We studied the role of VEGF-C in developing human lung, and in acute and chronic lung injury in preterm infants.
METHODS: Included in the immunohistochemistry study were 10 fetuses, 15 control neonates without primary lung disease, 15 preterm infants with respiratory distress syndrome, and 8 infants with bronchopulmonary dysplasia. Tracheal aspirate fluid samples of intubated very-low-birth-weight infants during Postnatal Weeks 1-5 were analyzed with ELISA.
RESULTS: Bronchiolar staining for VEGF-C was observed in all 48 samples. Alveolar epithelial staining was seen in most fetuses (8/10). In addition, staining was observed in alveolar macrophages in bronchopulmonary dysplasia (4/8), and late respiratory distress syndrome (2/7). VEGF receptor-3 (VEGFR-3) staining was observed in lymphatic endothelium adjacent to vascular endothelium. VEGF-C was expressed consistently in tracheal aspirate fluid, being highest during the first 2 postnatal days. Antenatal administration of glucocorticoids was associated with higher VEGF-C in tracheal aspirate fluid.
CONCLUSIONS: The pattern of pulmonary VEGF-C and VEGFR-3 protein expression and consistent VEGF-C protein appearance in tracheal aspirate fluid in human preterm infants indicate a role for VEGF-C in the physiologic development of the lymphatic system of the lung.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16690974     DOI: 10.1164/rccm.200508-1291OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  15 in total

Review 1.  Lymphatics in lung disease.

Authors:  Souheil El-Chemaly; Stewart J Levine; Joel Moss
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

2.  Vascular endothelial growth factor receptor 3 signaling contributes to angioobliterative pulmonary hypertension.

Authors:  Ayser Al-Husseini; Donatas Kraskauskas; Eleanora Mezzaroma; Andrea Nordio; Daniela Farkas; Jennifer I Drake; Antonio Abbate; Quentin Felty; Norbert F Voelkel
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

3.  Pulmonary Vasculopathy Associated with FIGF Gene Mutation.

Authors:  Evan Bailey; Ye Cui; Alicia Casey; Joan M Stoler; Xingbin Ai; Dongdong Ma; Robert Handin; Piotr Sliz; Sara O Vargas; Souheil Y El-Chemaly
Journal:  Am J Pathol       Date:  2016-11-12       Impact factor: 4.307

4.  Pulmonary vascular changes in piglets with increased pulmonary blood flow and pressure.

Authors:  Matthias Gorenflo; Esther Herpel; Michael V Ullmann; Karoline Röhlig; Sueha Demirakca; Homa Klimpel; Siegfried Hagl; Martha Maria Gebhard; Philipp A Schnabel
Journal:  Virchows Arch       Date:  2007-04-21       Impact factor: 4.064

5.  Variations in the vascular endothelial growth factor pathway predict pulmonary complications.

Authors:  Jae Y Kim; Michelle A T Hildebrandt; Xia Pu; Yuanqing Ye; Arlene M Correa; Ara A Vaporciyan; Xifeng Wu; Jack A Roth
Journal:  Ann Thorac Surg       Date:  2012-07-12       Impact factor: 4.330

6.  Deleted in malignant brain tumors 1 (DMBT1) elicits increased VEGF and decreased IL-6 production in type II lung epithelial cells.

Authors:  Hanna Müller; Christian Nagel; Christel Weiss; Jan Mollenhauer; Johannes Poeschl
Journal:  BMC Pulm Med       Date:  2015-04-08       Impact factor: 3.317

7.  Altered pulmonary lymphatic development in infants with chronic lung disease.

Authors:  Emily M McNellis; Sherry M Mabry; Eugenio Taboada; Ikechukwu I Ekekezie
Journal:  Biomed Res Int       Date:  2014-01-02       Impact factor: 3.411

8.  Gene expression profiling in preterm infants: new aspects of bronchopulmonary dysplasia development.

Authors:  Jacek J Pietrzyk; Przemko Kwinta; Embjorg J Wollen; Mirosław Bik-Multanowski; Anna Madetko-Talowska; Clara-Cecilie Günther; Mateusz Jagła; Tomasz Tomasik; Ola D Saugstad
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

9.  Lymphatic function is required prenatally for lung inflation at birth.

Authors:  Zoltán Jakus; Jason P Gleghorn; David R Enis; Aslihan Sen; Stephanie Chia; Xi Liu; David R Rawnsley; Yiqing Yang; Paul R Hess; Zhiying Zou; Jisheng Yang; Susan H Guttentag; Celeste M Nelson; Mark L Kahn
Journal:  J Exp Med       Date:  2014-04-14       Impact factor: 14.307

Review 10.  Lymphangiogenesis and Lesion Heterogeneity in Interstitial Lung Diseases.

Authors:  Masahiro Yamashita
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2016-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.